Pfizer Inc is trading at $25.20 (-2.76%) following the announcement that Chief Financial Officer Dave Denton will step down on August 15, 2026.
- The company has named Cecile Guegan as interim CFO, signaling an unexpected leadership change in the finance department.
- The decline appears company-specific as the broader market is generally firmer, suggesting the move is driven by internal uncertainty rather than macro sentiment.
- Shares also weakened in the prior session, reflecting investor concerns regarding the transition and future execution.